Future Planet Capital

Future Planet Capital is a venture capital firm founded in 2016 and based in London, United Kingdom. The firm specializes in capital growth and invests across various stages, including seed, early, mid, and late venture stages, as well as fund of funds investments. It focuses on companies that aim to commercialize research from UK universities, particularly in sectors addressing climate change, education, healthcare, security, and sustainable growth. By connecting large investors with innovative solutions, Future Planet Capital seeks to profitably tackle some of the world's most pressing challenges while supporting the development of breakthrough technologies.

Douglas Hansen-Luke

Executive Chairman

David Knox

Founding Director and Shareholder

Hassan Mahmudul

VC Investor

Griff Williams

Investment Director

Past deals in Birmingham

Diverse School Travel

Convertible Note in 2022
A vibrant UK based small business, offering schools and colleges some wonderful and exciting educational and cultural tours to schools and colleges throughout the UK, Europe, and beyond. Our head office is in the centre of Birmingham and our young, multi-lingual, and exceptionally talented(!) staff team is driven by ensuring all our customers are given the best possible price and service.

Midven

Acquisition in 2021
Midven is a venture capital firm located in Birmingham, United Kingdom, focusing on investing in early-stage and fast-growing small and medium-sized enterprises (SMEs). The firm provides financial support of up to £1 million, aiming to foster the growth of dynamic businesses. Midven is managed by an experienced team of investment professionals who take a hands-on approach to support the companies in their portfolio.

Linear Diagnostics

Venture Round in 2021
Linear Diagnostics Limited is a diagnostics company based in Birmingham, United Kingdom, that specializes in developing a novel diagnostic platform technology leveraging linear dichroism (LD). Founded in 2011, the company focuses on a wide range of applications, including the detection of antibiotic resistance in infections and the identification of bacteria responsible for crop spoilage. The platform enables simultaneous measurement of multiple targets from a single sample and utilizes various molecular recognition methods to enhance detection capabilities. Additionally, Linear Diagnostics offers a handheld reader for measuring linear dichroism signals, providing a streamlined and efficient approach to molecular diagnostics. The technology represents a significant advancement over existing methods, facilitating quicker and more accurate testing processes.

Learning Labs

Venture Round in 2020
Learning Labs operates an online educational platform designed to make language learning accessible to all students. The organization comprises a diverse team of former educators, linguists, and technology professionals who focus on enhancing engagement and learning outcomes in foreign language acquisition. By integrating lessons, games, and adaptive technology, the platform aims to foster effective learning experiences that help users improve their language skills and expand their vocabulary. The use of smartphones and tablets further facilitates this innovative approach to education, making language learning both engaging and effective.

Zipabout

Seed Round in 2019
Zipabout Limited is a UK-based company founded in 2011 that specializes in data aggregation and communication applications for the transport industry. The company has developed a big-data platform that integrates advanced technologies with extensive data sets to provide operational, environmental, and behavioral insights for passengers and transport operators. Zipabout focuses on delivering personalized passenger communications to facilitate seamless multi-modal journeys tailored to individual needs. Its innovative products, including the real-time Passenger Connect platform, provide essential knowledge and insights to policymakers, transport operators, and travelers, enhancing the overall travel experience.

Linear Diagnostics

Venture Round in 2019
Linear Diagnostics Limited is a diagnostics company based in Birmingham, United Kingdom, that specializes in developing a novel diagnostic platform technology leveraging linear dichroism (LD). Founded in 2011, the company focuses on a wide range of applications, including the detection of antibiotic resistance in infections and the identification of bacteria responsible for crop spoilage. The platform enables simultaneous measurement of multiple targets from a single sample and utilizes various molecular recognition methods to enhance detection capabilities. Additionally, Linear Diagnostics offers a handheld reader for measuring linear dichroism signals, providing a streamlined and efficient approach to molecular diagnostics. The technology represents a significant advancement over existing methods, facilitating quicker and more accurate testing processes.

Cytox

Series B in 2017
Cytox Limited is focused on developing products and services aimed at addressing neurodegenerative disorders, particularly Alzheimer's disease (AD). The company specializes in cellular and genetic assays that facilitate the diagnosis and treatment of AD, leveraging the cell division cycle theory of its pathogenesis. It has created a genetic-based blood test designed for early-stage risk assessment and diagnosis of Alzheimer's disease. Cytox also offers biomarker and drug-screening services to pharmaceutical companies engaged in clinical trials for AD and mild cognitive impairment treatments. By collaborating with Affymetrix, a part of Thermo Fisher Scientific, Cytox supports the development of novel therapeutics aimed at combating this growing condition, which currently affects millions worldwide. Founded in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox serves a global clientele that includes pharmaceutical and biotechnology firms, as well as research laboratories.

Linear Diagnostics

Seed Round in 2017
Linear Diagnostics Limited is a diagnostics company based in Birmingham, United Kingdom, that specializes in developing a novel diagnostic platform technology leveraging linear dichroism (LD). Founded in 2011, the company focuses on a wide range of applications, including the detection of antibiotic resistance in infections and the identification of bacteria responsible for crop spoilage. The platform enables simultaneous measurement of multiple targets from a single sample and utilizes various molecular recognition methods to enhance detection capabilities. Additionally, Linear Diagnostics offers a handheld reader for measuring linear dichroism signals, providing a streamlined and efficient approach to molecular diagnostics. The technology represents a significant advancement over existing methods, facilitating quicker and more accurate testing processes.

Breaking Free Group

Convertible Note in 2015
Breaking Free Group is a digital health provider based in Birmingham and Manchester, focused on combating addictions through behavioral science. The company specializes in addressing substance use disorders across various treatment environments, including public health and correctional settings. By leveraging real-time data analytics, Breaking Free Group helps patients identify and tackle the psychological and lifestyle factors contributing to their addictive behaviors.

Diverse School Travel

Funding Round in 2015
A vibrant UK based small business, offering schools and colleges some wonderful and exciting educational and cultural tours to schools and colleges throughout the UK, Europe, and beyond. Our head office is in the centre of Birmingham and our young, multi-lingual, and exceptionally talented(!) staff team is driven by ensuring all our customers are given the best possible price and service.

Geospatial Insight

Seed Round in 2015
Geospatial Insight is a provider of independent research derived from the analysis of satellite imagery and the integration of this intelligence with a range of other data sources. The company delivers these differentiated insights as investment research to the finance sector, business intelligence for corporate clients, and CAT event loss estimation and claims analysis services for the insurance sector. Established in 2012, Geospatial Insight has expanded the team to include finance sector specialists.

Diverse School Travel

Funding Round in 2014
A vibrant UK based small business, offering schools and colleges some wonderful and exciting educational and cultural tours to schools and colleges throughout the UK, Europe, and beyond. Our head office is in the centre of Birmingham and our young, multi-lingual, and exceptionally talented(!) staff team is driven by ensuring all our customers are given the best possible price and service.

Etive

Series A in 2014
Etive Technologies Limited specializes in providing digital data handling solutions for personal and property information through its web-based log book products. The company offers a Digital Log Book for individuals to create a digital identity and manage their personal information, and a Home Log Book that assists home developers by streamlining the buying process and enhancing post-occupancy customer service. The Home Log Book serves as a comprehensive record of property-related activities and improvements made during construction, while the Energy Log Book monitors home energy usage. Etive's services cater to a diverse clientele, including local authorities, housing associations, new home builders, healthcare providers, financial services, and estate agencies. Founded in 2011 and originally called Home Log Book Solutions Limited, the company rebranded to Etive Technologies Limited in 2013 and operates from offices in Edinburgh and Birmingham, United Kingdom.

Cytox

Series A in 2014
Cytox Limited is focused on developing products and services aimed at addressing neurodegenerative disorders, particularly Alzheimer's disease (AD). The company specializes in cellular and genetic assays that facilitate the diagnosis and treatment of AD, leveraging the cell division cycle theory of its pathogenesis. It has created a genetic-based blood test designed for early-stage risk assessment and diagnosis of Alzheimer's disease. Cytox also offers biomarker and drug-screening services to pharmaceutical companies engaged in clinical trials for AD and mild cognitive impairment treatments. By collaborating with Affymetrix, a part of Thermo Fisher Scientific, Cytox supports the development of novel therapeutics aimed at combating this growing condition, which currently affects millions worldwide. Founded in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox serves a global clientele that includes pharmaceutical and biotechnology firms, as well as research laboratories.

Diverse School Travel

Seed Round in 2013
A vibrant UK based small business, offering schools and colleges some wonderful and exciting educational and cultural tours to schools and colleges throughout the UK, Europe, and beyond. Our head office is in the centre of Birmingham and our young, multi-lingual, and exceptionally talented(!) staff team is driven by ensuring all our customers are given the best possible price and service.

Cytox

Series A in 2013
Cytox Limited is focused on developing products and services aimed at addressing neurodegenerative disorders, particularly Alzheimer's disease (AD). The company specializes in cellular and genetic assays that facilitate the diagnosis and treatment of AD, leveraging the cell division cycle theory of its pathogenesis. It has created a genetic-based blood test designed for early-stage risk assessment and diagnosis of Alzheimer's disease. Cytox also offers biomarker and drug-screening services to pharmaceutical companies engaged in clinical trials for AD and mild cognitive impairment treatments. By collaborating with Affymetrix, a part of Thermo Fisher Scientific, Cytox supports the development of novel therapeutics aimed at combating this growing condition, which currently affects millions worldwide. Founded in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox serves a global clientele that includes pharmaceutical and biotechnology firms, as well as research laboratories.

Breaking Free Group

Funding Round in 2012
Breaking Free Group is a digital health provider based in Birmingham and Manchester, focused on combating addictions through behavioral science. The company specializes in addressing substance use disorders across various treatment environments, including public health and correctional settings. By leveraging real-time data analytics, Breaking Free Group helps patients identify and tackle the psychological and lifestyle factors contributing to their addictive behaviors.

Breaking Free Group

Seed Round in 2011
Breaking Free Group is a digital health provider based in Birmingham and Manchester, focused on combating addictions through behavioral science. The company specializes in addressing substance use disorders across various treatment environments, including public health and correctional settings. By leveraging real-time data analytics, Breaking Free Group helps patients identify and tackle the psychological and lifestyle factors contributing to their addictive behaviors.

Breaking Free Group

Funding Round in 2010
Breaking Free Group is a digital health provider based in Birmingham and Manchester, focused on combating addictions through behavioral science. The company specializes in addressing substance use disorders across various treatment environments, including public health and correctional settings. By leveraging real-time data analytics, Breaking Free Group helps patients identify and tackle the psychological and lifestyle factors contributing to their addictive behaviors.

pr2go.com

Series A in 2010
pr2go is an affordable PR agency for businesses of all sizes. We specialise in PR press release writing and media distribution to get your business press release stories in front of your customers and potential customers – fast.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.